[{"Assets_0_Q2_USD":84175000.0,"CommonStockSharesOutstanding_0_Q2_shares":74688283.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-27622000.0,"NetIncomeLoss_1_Q2_USD":-14878000.0,"NetIncomeLoss_2_Q2_USD":-27910000.0,"StockholdersEquity_0_Q2_USD":70471000.0,"Ticker":"SRRA","CIK":"1290149","name":"SIERRA ONCOLOGY, INC.","OfficialName":"Sierra Oncology Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1244659116.0","Country":"Canada","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]